Rijsketic, Daniel Ryskamp http://orcid.org/0000-0002-2197-0730
Casey, Austen B. http://orcid.org/0000-0002-4670-851X
Barbosa, Daniel A. N. http://orcid.org/0000-0001-7272-1446
Zhang, Xue
Hietamies, Tuuli M.
Ramirez-Ovalle, Grecia
Pomrenze, Matthew B.
Halpern, Casey H.
Williams, Leanne M. http://orcid.org/0000-0001-9987-7360
Malenka, Robert C. http://orcid.org/0000-0002-5428-5211
Heifets, Boris D. http://orcid.org/0000-0003-1474-0379
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P50DA042012, P50DA042012)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 23 February 2023
Revised: 25 April 2023
Accepted: 15 May 2023
First Online: 29 May 2023
Competing interests
: LMW has served as a scientific advisor for One Mind Psyberguide, a member of the executive advisory board for the Laureate Institute for Brain Research and holds patent 16921388 (Systems and Methods for Detecting Complex Networks in MRI Image Data) unrelated to the present study. RCM is on the scientific advisory boards of MapLight Therapeutics, Bright Minds, MindMed, Cyclerion, AZTherapies, and Aelis Farma. BDH is on the scientific advisory boards of Osmind and Journey Clinical and is a consultant for Clairvoyant Therapeutics and Vine Ventures. The remaining authors have nothing to disclose.